tiprankstipranks
Trending News
More News >
Ligand Pharma (LGND)
NASDAQ:LGND

Ligand Pharma (LGND) Revenue

Compare
834 Followers

Ligand Pharma Revenue

Ligand Pharma had a revenue of 59.67M in the quarter ending Dec 31, 2025, with -48.32%. This bring the company's revenue in the last twelve months to 268.09M, Decreased 6.71%. In the fiscal year ending Dec 31, 2025, Ligand Pharma had annual revenue of 268.09M with 60.40% growth.
Revenue (ttm)
268.09M
Revenue Growth
64.83%
P/S Ratio
15.69
Revenue/Employee
$3,942,456
Employees
68
Market Cap
$4.21B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
268.09M100.95M+60.40%
Dec 31, 2024
167.13M35.82M+27.28%
Dec 31, 2023
131.31M-64.93M-33.09%
Dec 31, 2022
196.25M-45.30M-18.75%
Dec 31, 2021
241.54M77.98M+47.68%
Dec 31, 2020
163.56M43.28M+35.98%
Dec 31, 2019
120.28M-131.17M-52.17%
Dec 31, 2018
251.45M110.35M+78.21%
Dec 31, 2017
141.10M